Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Other financing activities (2021 - 2022)

Biote (BTMD) has 2 years of Other financing activities data on record, last reported at -$4.3 million in Q3 2022.

  • For Q3 2022, Other financing activities changed N/A year-over-year to -$4.3 million; the TTM value through Dec 2022 reached $4.0 million, up 2.41%, while the annual FY2022 figure was $4.0 million, 2.41% up from the prior year.
  • Other financing activities reached -$4.3 million in Q3 2022 per BTMD's latest filing, down from $6.8 million in the prior quarter.
  • Across five years, Other financing activities topped out at $6.8 million in Q2 2022 and bottomed at -$4.3 million in Q3 2022.